Related Experiment Video
Updated: Jun 9, 2025
Chinese Herbal Retention Enema for the Treatment of Ulcerative Colitis
Published on: May 16, 2025
Management of ulcerative colitis: where are we at and where are we heading?
Adnan Abbas1, David M P Di Fonzo2, Panu Wetwittayakhlang1,3
1Division of Gastroenterology and Hepatology, Department of Medicine, McGill University, Health Centre, Montreal, Canada.
Introduction:
Remission rates for ulcerative colitis (UC) remain low despite significant progress in disease understanding and the introduction of novel therapeutic agents. Several challenges contribute to this, including the heterogeneity of the disease, suboptimal efficacy of current diagnostic and therapeutic tools, drug safety concerns, and limited access to newer treatment options.
Areas Covered:
This review evaluates current treatment targets in UC, assessing the effectiveness of various therapies and management strategies in achieving remission. We explore the potential role of personalized medicine, which tailors treatment based on clinical predictors, genetic factors, and immunologic profiles. Personalized approaches show promise in improving remission rates by addressing the unique characteristics of each patient. We also discussed the feasibility of adapting such management models and suggested solutions to some of the challenges in their implementation.
Expert Opinion:
Future efforts should prioritize the continued development of biologics, small molecules, and digital health solutions, alongside noninvasive monitoring techniques. These innovations could not only enhance patient outcomes by improving remission rates but also reduce healthcare costs by minimizing hospitalization and surgical interventions. Ultimately, a personalized, stratified approach to UC management is key to optimizing patient care and addressing the unmet needs in this field.
Insights
Achieving remission in ulcerative colitis (UC) is challenging due to disease complexity. Personalized medicine, tailoring treatments to individual patient profiles, offers a promising strategy to improve remission rates and optimize care.
Area of Science:
- Gastroenterology and Immunology
- Pharmacology and Therapeutics
Background:
- Ulcerative colitis (UC) exhibits significant heterogeneity, contributing to low remission rates despite advancements in treatment.
- Current diagnostic and therapeutic tools for UC have suboptimal efficacy, alongside drug safety concerns and limited access to novel therapies.
Purpose of the Study:
- To review current treatment targets for ulcerative colitis (UC).
- To assess the effectiveness of various therapies and management strategies in achieving remission.
- To explore the role of personalized medicine in improving UC remission rates.
Main Methods:
- Literature review of current ulcerative colitis (UC) treatment strategies.
- Evaluation of personalized medicine approaches based on clinical, genetic, and immunologic predictors.
- Analysis of challenges and solutions for implementing personalized UC management models.
Main Results:
- Personalized medicine, tailoring treatment to individual patient profiles, shows promise for improving UC remission rates.
- Addressing disease heterogeneity and individual characteristics is crucial for effective UC management.
- Feasibility of adapting personalized management models and potential implementation strategies were discussed.
Conclusions:
- Continued development of biologics, small molecules, and digital health solutions is essential for advancing UC care.
- Noninvasive monitoring techniques and personalized, stratified approaches are key to optimizing patient outcomes and reducing healthcare costs.
- Personalized management strategies are vital for addressing unmet needs in ulcerative colitis (UC).
More Related Videos
Related Concept Videos
01:29Drugs for Treatment of Ulcerative Colitis in IBD
01:21Inflammatory Bowel Disease V: Surgical Management
Here are some common surgical interventions for IBD:
01:29Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
01:27Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
01:26Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...